Dr. Eva Oswald is an Associate Research Director at the Charles River Laboratories in Freiburg, Germany. She is responsible for new model development in vivo, which includes establishing new PDX models, developing different test systems for immuno-oncology applications in vivo, including cell and gene therapy, immune checkpoint inhibition, and bispecific antibodies. She completed her PhD in the Department of Dermatology, working on autoimmune cutaneous blistering diseases. With her knowledge of immunology and heading labs for flow cytometry and innovative models at Oncotest/Charles River, she is now perfectly qualified to provide guidance to our clients in the immunooncology field for pre-clinical in vivo models.
Eva Oswald, Dr. rer. nat.
Associate Research Director